Production and characterization of monoclonal antibodies specific for canine CD138 (syndecan-1) for nuclear medicine preclinical trials on spontaneous tumours

Abstract : We isolated 11 antibodies specific for canine CD138 (cCD138) to validate the interest of CD138 antigen targeting in dogs with spontaneous mammary carcinoma. The affinity of the monoclonal antibodies in the nanomolar range is suitable for immunohistochemistry and nuclear medicine applications. Four distinct epitopes were recognized on cCD138 by this panel of antibodies. CD138 expression in canine healthy tissues is comparable to that reported in humans. CD138 is frequently expressed in canine mammary carcinomas corresponding to the human triple negative breast cancer subtype, with cytoplasmic and membranous expression. In canine diffuse large B-cell lymphoma, CD138 expression is associated with the 'non-germinal center' phenotype corresponding to the most aggressive subtype in humans. This homology of CD138 expression between dogs and humans confirms the relevance of tumour-bearing dogs as spontaneous models for nuclear medicine applications, especially for the evaluation of new tumour targeting strategies for diagnosis by phenotypic imaging and radio-immunotherapy.
Type de document :
Article dans une revue
Veterinary and Comparative Oncology, Wiley, 2016, [Epub ahead of print]. 〈10.1111/vco.12233〉
Liste complète des métadonnées

Littérature citée [46 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-01414822
Contributeur : Elizabeth Bernardo <>
Soumis le : lundi 12 décembre 2016 - 15:52:02
Dernière modification le : jeudi 20 septembre 2018 - 17:02:01
Document(s) archivé(s) le : mardi 28 mars 2017 - 00:09:28

Fichier

 Accès restreint
Fichier visible le : jamais

Connectez-vous pour demander l'accès au fichier

Identifiants

Collections

Citation

Maya Diab, Frédérique Nguyen, Maxime Berthaud, Catherine Maurel, J. Gaschet, et al.. Production and characterization of monoclonal antibodies specific for canine CD138 (syndecan-1) for nuclear medicine preclinical trials on spontaneous tumours. Veterinary and Comparative Oncology, Wiley, 2016, [Epub ahead of print]. 〈10.1111/vco.12233〉. 〈inserm-01414822〉

Partager

Métriques

Consultations de la notice

83